These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2263063)

  • 1. Direct automated EMIT d.a.u. analysis of N,N-dimethylformamide-modified serum, plasma, and postmortem blood for amphetamines, barbiturates, methadone, methaqualone, phencyclidine, and propoxyphene.
    Klinger RA; Blum LM; Rieders F
    J Anal Toxicol; 1990; 14(5):288-91. PubMed ID: 2263063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct automated EMIT d.a.u. analysis of N,N-dimethylformamide-modified serum, plasma, and postmortem blood for benzodiazepines, benzoylecgonine, cannabinoids, and opiates.
    Blum LM; Klinger RA; Rieders F
    J Anal Toxicol; 1989; 13(5):285-8. PubMed ID: 2693833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct detection of drugs of abuse in whole hemolyzed blood using the EMIT d.a.u. urine assays.
    Asselin WM; Leslie JM; McKinley B
    J Anal Toxicol; 1988; 12(4):207-15. PubMed ID: 3054319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
    Marin SJ; Keith L; Merrell M; McMillin GA
    J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an automated microplate enzyme immunoassay for screening of postmortem blood for drugs of abuse.
    Spiehler VR; Collison IB; Sedgwick PR; Perez SL; Le SD; Farnin DA
    J Anal Toxicol; 1998; 22(7):573-9. PubMed ID: 9847007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abbott phencyclidine and barbiturates abused drug assays: evaluation and comparison of ADx FPIA, TDx FPIA, EMIT, and GC/MS methods.
    Caplan YH; Levine B
    J Anal Toxicol; 1989; 13(5):289-92. PubMed ID: 2693834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel procedure for the analysis of drugs in whole blood by homogeneous enzyme immunoassay (EMIT).
    Lewellen LJ; McCurdy HH
    J Anal Toxicol; 1988; 12(5):260-4. PubMed ID: 2906382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setting cutoff concentrations for immunoassay screening of postmortem blood.
    Collison IB; Spiehler VR; Guluzian S; Sedgwick PR
    J Forensic Sci; 1998 Mar; 43(2):390-4. PubMed ID: 9544549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
    Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
    Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New fluorescence polarization immunoassays for analysis of barbiturates and benzodiazepines in serum and urine: performance characteristics.
    Schwenzer KS; Pearlman R; Tsilimidos M; Salamone SJ; Cannon RC; Wong SH; Gock SB; Jentzen JJ
    J Anal Toxicol; 2000; 24(8):726-32. PubMed ID: 11110029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of the EMIT drug abuse urine assay methods.
    Allen LV; Stiles ML
    Clin Toxicol; 1981 Sep; 18(9):1043-65. PubMed ID: 7032834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study.
    Bogusz M; Aderjan R; Schmitt G; Nadler E; Neureither B
    Forensic Sci Int; 1990 Nov; 48(1):27-37. PubMed ID: 2279719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study.
    Schwettmann L; Külpmann WR; Vidal C
    Clin Chem Lab Med; 2006; 44(4):479-87. PubMed ID: 16599844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol, marijuana, and other drug use in 600 drivers killed in single-vehicle crashes in North Carolina, 1978-1981.
    Mason AP; McBay AJ
    J Forensic Sci; 1984 Oct; 29(4):987-1026. PubMed ID: 6502125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Triage screening for drugs of abuse in postmortem blood and urine samples.
    Moriya F; Hashimoto Y
    Nihon Hoigaku Zasshi; 1997 Jun; 51(3):214-9. PubMed ID: 9301227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the Triage panel for drugs of abuse to forensic blood samples.
    Moriya F; Hashimoto Y
    Nihon Hoigaku Zasshi; 1996 Apr; 50(2):50-6. PubMed ID: 8691649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of DRI enzyme immunoassays for drugs-of-abuse screening on the Cobas Mira.
    Broussard LA; Hanson L
    Clin Lab Sci; 1997; 10(2):83-6. PubMed ID: 10166356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine.
    Kunsman GW; Manno JE; Cockerham KR; Manno BR
    J Anal Toxicol; 1990; 14(3):149-53. PubMed ID: 1973747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Emit II reagents on the Chem 1.
    Sreenivasam RC; Sneath TC; Jain NC
    J Anal Toxicol; 1993 Oct; 17(6):370-3. PubMed ID: 8271784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the TRI Dipstick test for the detection of drugs of abuse in urine.
    Wallace JA; Blum K
    Subst Alcohol Actions Misuse; 1982; 3(1-2):129-32. PubMed ID: 6753193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.